Investigating the interrelatedness of clinical and non-clinical parameters affecting outcomes in COVID-19 patients: a retrospective study

References

• Rastad H, Karim H, Ejtahed HS, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020;12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Patel P, Hiam L, Sowemimo A, et al. Ethnicity and covid-19. BMJ. 2020;369(8249):1–2.
   Google Scholar
• Zhou Y, He Y, Yang H, et al. Development and validation a nomogram for predicting the risk of severe COVID-19: a multi-center study in Sichuan, China. PLoS One. 2020;15(5):e0233328.
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362.
   PubMed Web of Science ®Google Scholar
• Meng L, Qiu H, Wan L, et al. Intubation and ventilation amid the COVID-19 outbreak: Wuhan’s experience. Anesthesiology. 2020;132(6):1317–1332.
   PubMed Web of Science ®Google Scholar
• Ilyas N, Azuine RE, Tamiz A. COVID-19 pandemic in Pakistan. Int J Trans Med Res Public Health. 2020;4(1):37–49.
   Google Scholar
• Chaudhry A, Ikram A, Baig MA, et al. Mortality analysis of COVID-19 confirmed cases in Pakistan. medRxiv. 2020.
   PubMedGoogle Scholar
• Waris A, Atta UK, Ali M, et al. COVID-19 outbreak: current scenario of Pakistan. New Microbes New Infect. 2020;35:100681.
   PubMed Web of Science ®Google Scholar
• Abid K, Bari YA, Younas M, et al. Progress of COVID-19 epidemic in Pakistan. Asia Pac J Public Health. 2020;32(4):154–156.
   PubMed Web of Science ®Google Scholar
• Demombynes G. COVID-19 age-mortality curves are flatter in developing countries. World Bank. 2020.
   Google Scholar
• Caramelo F, Ferreira N, Oliveiros B. Estimation of risk factors for COVID-19 mortality-preliminary results. MedRxiv. 2020.
   Google Scholar
• Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.
   PubMed Web of Science ®Google Scholar
• Martins-Filho PR, de Souza Araújo AA, Pereira LX, et al. Factors associated with mortality among hospitalized patients with COVID-19: a retrospective cohort study. Am J Trop Med Hyg. 2021;104(1):103.
   PubMed Web of Science ®Google Scholar
• Cook TM. The importance of hypertension as a risk factor for severe illness and mortality in COVID‐19. Anaesthesia. 2020;75(7):976.
   PubMed Web of Science ®Google Scholar
• Goyal DK, Mansab F, Iqbal A, et al. Early intervention likely improves mortality in COVID-19 infection. Clin Med (Lond). 2020;20(3):248–250. Advance online publication.
   PubMed Web of Science ®Google Scholar
• Shi L, Wang Y, Wang Y, et al. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. J Infect. 2020;81(4):647–679.
   PubMed Web of Science ®Google Scholar
• Soares RDCM, Mattos LR, Raposo LM. Risk factors for hospitalization and mortality due to COVID-19 in Espírito Santo State, Brazil. Am J Trop Med Hyg. 2020;103(3):1184.
   PubMed Web of Science ®Google Scholar
• Chen T, Wu DI, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368(8240):1–11.
   Google Scholar
• Nidadavolu LS, Walston JD. Underlying vulnerabilities to the cytokine storm and adverse COVID-19 outcomes in the aging immune system. J Gerontol A. 2021;76(3):e13–e18.
   Google Scholar
• Poco PCE, Aliberti MJR, Dias MB, et al. Divergent: age, frailty, and atypical presentations of COVID-19 in hospitalized patients. J Gerontol A. 2021;76(3):e46–e51.
   Google Scholar
• Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China. Mech Ageing Dev. 2020;188:111255.
   PubMed Web of Science ®Google Scholar
• Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its impact on patients with COVID-19. SN Compreh Clin Med. 2020;2(8):1–8.
   Google Scholar
• Singh AK, Gupta R, Ghosh A, et al. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303–310.
   PubMed Web of Science ®Google Scholar
• Alrashed AA, Khan TM, Alhusseini NK, et al. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: a retrospective cohort study. J Infect Public Health. 2021;14(6):726–733.
   PubMed Web of Science ®Google Scholar
• Feng G, Zheng KI, Yan QQ, et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 2020;8(1):18–24.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Li L, Samplaski M. Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone? Andrology. 2021;9(1):65–72.
   PubMed Web of Science ®Google Scholar
• Barek MA, Aziz MA, Islam MS. Impact of age, sex, comorbidities and clinical symptoms on the severity of COVID-19 cases: a meta-analysis with 55 studies and 10014 cases. Heliyon. 2020;6(12):e05684.
   PubMed Web of Science ®Google Scholar
• Hu Q, Hao C, Tang S. From sepsis to acute respiratory distress syndrome (ARDS): emerging preventive strategies based on molecular and genetic researches. Biosci Rep. 2020;40(5):BSR20200830.
   PubMedGoogle Scholar
• Cheng X, Cai G, Wen X, et al. Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19. Aging (Albany NY). 2020;12(23):23436.
   PubMedGoogle Scholar
• Youn JC, Yu HT, Lim BJ, et al. Immunosenescent CD8+ T cells and CXC chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension. 2013;62(1):126–133.
   PubMed Web of Science ®Google Scholar
• Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes Metab Res Rev. 2020;36(7):e3319.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Chen J, et al. COVID‐19 infection may cause ketosis and ketoacidosis. Diabetes Obesity Metab. 2020;22(10):1935–1941.
   PubMed Web of Science ®Google Scholar
• Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 2010;138(3):559–567.
   PubMed Web of Science ®Google Scholar
• Alobaidi R, Basu RK, Goldstein SL, et al. (2015). Sepsis-associated acute kidney injury. Seminars in Nephrology. 35(1):2–11.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–828.
   PubMed Web of Science ®Google Scholar
• Zarbock A, Gomez H, Kellum JA. Sepsis-induced AKI revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care. 2014;20(6):588.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med. 2020;383(19):1813–1826.
   PubMed Web of Science ®Google Scholar
• Spinner CD, Gottlieb RL, Criner GJ, et al. Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial. Jama. 2020;324(11):1048–1057.
   PubMed Web of Science ®Google Scholar
• Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur J Prev Cardiol. 2020;27(13):1436–1437.
   PubMed Web of Science ®Google Scholar
• Wu Y, Feng Z, Li P, et al. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020;509:220–223.
   PubMed Web of Science ®Google Scholar
• Groot HE, Villegas Sierra LE, Said MA, et al. Genetically determined ABO blood group and its associations with health and disease. Arterioscler Thromb Vasc Biol. 2020;40(3):830–838.
   PubMed Web of Science ®Google Scholar
• Jaber S, Saleh HA, Hussein RA. Frequency and prognostic value of abo blood groups in patients with hypertension, obesity, diabetes mellitus, and anemia in local population of Al-Najaf City/Iraq. Indian J Forensic Med Toxicol. 2021;15(3):701–709.
   Google Scholar
• Fan Q, Zhang W, Li B, et al. Association between ABO blood group system and COVID-19 susceptibility in Wuhan. Front Cell Infect Microbiol. 2020;10:404.
   PubMed Web of Science ®Google Scholar